Net Loss per Share (Tables)

9 Months Ended

Sep. 30, 2023

Schedule of potential dilutive securities that would have been anti-dilutive due to net loss

The following securities have been excluded from the calculation of weighted-average shares of common stock outstanding because the effect is anti-dilutive for each of the periods indicated.


	Three and Nine Months Ended September 30,
	2023	2022

Stock options	4,744,465	5,428,679
Restricted stock units	5,498,359	4,594,782
Performance restricted stock units	1,946,407	2,248,104
Shares related to convertible senior notes	29,776,706	13,443,374
Total antidilutive securities	41,965,937	25,714,939

Schedule of calculation of basic and diluted net loss per share

The following table presents the calculation of the Company’s basic and diluted net loss per share for each of the periods indicated.


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022

Numerator (in thousands):
Net loss	$	(47,443)	$	(121,676)	$	(275,159)	$	(310,308)
Denominator:
Weighted-average shares of common stock outstanding, basic and diluted	81,515,246		77,692,911		80,470,221		77,013,180
Net loss per share, basic and diluted	$	(0.58)	$	(1.57)	$	(3.42)	$	(4.03)